Moderna Inc (MRNA)
$58.57 3.02 (4.90%)
19:59 EDT MRNA Stock Quote Delayed 30 Minutes
Previous Close $58.57
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 26.54M
Day's Range 55.81 - 61.80
52-Week Range 11.54 - 87.00
Dividend & Yield N/A (N/A)
MRNA Stock Predictions, Articles, and Moderna Inc News
- From InvestorPlace
- From the Web
Nio, JPMorgan, Moderna and DocuSign were our top stock trades from Thursday. Let's look at the charts ahead of next week.
The popularity of Robinhood is creating ripples of buying signals for investors.
Covid-19 vaccine stocks are on fire, but many of them appear to be out over their skis, including the group's hottest name, NVAX stock.
With pandemic fears shuttering many economies, most investments have cratered. However, a small group of coronavirus stocks may offer significant upside potential.
These seven A- and B-rated names are some of the top risky stocks to buy for enterprising investors. Here's what you should know about each company.
With demand sky-high for a coronavirus vaccine, it was only natural that MRNA stock jumped higher on Moderna’s encouraging early stage clinical trial results. However, its questionable practices are now coming into closer view.
Positive results and a key supply agreement for Moderna highlight the bull case for MRNA stock as a promising coronavirus play.
Moderna has become the stock market's great hope for a Covid-19 vaccine, but there are dozens of other candidates.
A race to develop a coronavirus vaccine is on, and these red-hot Covid-19 vaccine stocks are leading the way.
Data from the Phase 1 trial of Moderna's coronavirus vaccine was mixed, making MRNA stock risky at its current levels.
Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.
We're starting to see some light at the end of the coronavirus tunnel, and investors are looking at stocks to buy for a post-crisis bump.
MRNA stock is a big bet right now, but it also reaps huge rewards if Moderna’s promising trials hold up to further testing.
Target, Lowe's, McKesson and Moderna were our top stock trades for Thursday. That said, here's what the charts look like now.
By Joel Baglole
MRNA stock continues to reach new highs, leaving investors wondering if Moderna's rally is sustainable over the long term.
Facebook is launching a Shops feature, while Apple buys up old video content. Here's what's happening in the stock market today.
Moderna, a stock that doesn't reside in the Dow Jones Industrial Average, sent the blue chip index soaring to start the week.
Nvidia caught a huge price target increase, while Apple looks to reopen its stores. Here's what happened in the stock market today.
From Market News Video
Investors in HCA Healthcare Inc (HCA) saw new options begin trading today, for the August 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HCA options chain for the new August 14th contracts and identified one put and one call contract of particular interest.
From Talk Markets
Navellier RatingsPowered by Portfolio Grader